Description
CD40 (Selicrelumab Biosimilar) Human mAb was confirmed to bind to its intended target protein Selicrelumab using flow cytometry. CD40 (Selicrelumab Biosimilar) Human mAb is produced at Cell Signaling Technology. Selicrelumab is an antibody directed to bind to the extracellular domain of CD40.
Target
CD40
Target Alias Name
CD40
Isotype/Mimetic
IgG2 kappa
Animal-Derived Biomaterials Used
BSA
Sequence Available
Yes
Original Discovery Method
Immunization
Antibody/Binder Origins
Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation